Subject- And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, 3-Way Crossover Study To Study Effects Of PF-04802540 On Polysomnography Endpoints In Healthy Volunteers.

Trial Profile

Subject- And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, 3-Way Crossover Study To Study Effects Of PF-04802540 On Polysomnography Endpoints In Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Mar 2010

At a glance

  • Drugs TS 032 (Primary)
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Apr 2009 Actual patient number (13) added as reported by ClinicalTrials.gov.
    • 07 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2008 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top